奥妥珠单抗治疗原发性膜性肾病的有效性及安全性

Description

Conclusion: Obinutuzumab is an effective and safe treatment option for PMN, characterised by high clinical remission rates, a favourable safety profile, and the ability to stabilise renal function. It also demonstrates significant efficacy in refractory and RTX-resistant patients.

Institutions

• Shandong Provincial Hospital

  Shandong, Jinan

Categories

Licence